Centerpoint Advisors’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-275
Closed -$19K – 485
2026
Q2
$19K Buy
275
+51
+23% +$3.46K 0.01% 280
2026
Q1
$17K Hold
224
– – 0.01% 269
2025
Q4
$17K Hold
224
– – 0.01% 284
2025
Q3
$19K Sell
224
-1
-0.4% -$80 0.01% 267
2025
Q2
$18K Buy
225
+47
+26% +$3.46K 0.01% 272
2025
Q1
$13K Hold
178
– – ﹤0.01% 303
2024
Q4
$16K Hold
178
– – 0.01% 305
2024
Q3
$15K Hold
178
– – 0.01% 323
2024
Q2
$16K Sell
178
-2
-1% -$202 0.01% 304
2024
Q1
$20K Hold
180
– – 0.01% 248
2023
Q4
$17K Hold
180
– – 0.01% 283
2023
Q3
$17K Sell
180
-2
-1% -$215 0.01% 261
2023
Q2
$22K Hold
182
– – 0.01% 233
2023
Q1
$18K Buy
182
+30
+20% +$2.86K 0.01% 277
2022
Q4
$12K Buy
+152
New +$12.8K 0.01% 294

Other funds holding USPH

Centerpoint Advisors's USPH Position: Q3 2026 in Review

Centerpoint Advisors sold out of US Physical Therapy (USPH) in Q3 2026, closing a stake of 275 shares — an estimated $19K sold.

Centerpoint Advisors first reported a position in USPH in Q4 2022 and held it in 15 quarters. The position peaked at $22K in Q2 2023. 104 funds tracked by Wall St. Rank hold USPH as of Q3 2026.

  • Centerpoint Advisors reported no remaining US Physical Therapy position as of Q3 2026 after selling out during the quarter.
  • Centerpoint Advisors sold 275 US Physical Therapy shares in Q3 2026, an estimated $19K.
  • Centerpoint Advisors first reported a position in US Physical Therapy in Q4 2022 and held it in 15 quarters.
  • Centerpoint Advisors's US Physical Therapy position peaked at $22K in Q2 2023.
  • 104 funds tracked by Wall St. Rank held US Physical Therapy as of Q3 2026.

Based on Centerpoint Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.